These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25019406)

  • 21. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
    Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
    Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle.
    Cheng YL; Lan KH; Lee WP; Tseng SH; Hung LR; Lin HC; Lee FY; Lee SD; Lan KH
    Clin Sci (Lond); 2013 Nov; 125(9):439-48. PubMed ID: 23659500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
    Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
    Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus entry.
    Zeisel MB; Felmlee DJ; Baumert TF
    Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
    Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
    J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.
    Takebe Y; Saucedo CJ; Lund G; Uenishi R; Hase S; Tsuchiura T; Kneteman N; Ramessar K; Tyrrell DL; Shirakura M; Wakita T; McMahon JB; O'Keefe BR
    PLoS One; 2013; 8(5):e64449. PubMed ID: 23700478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
    Haid S; Novodomská A; Gentzsch J; Grethe C; Geuenich S; Bankwitz D; Chhatwal P; Jannack B; Hennebelle T; Bailleul F; Keppler OT; Poenisch M; Bartenschlager R; Hernandez C; Lemasson M; Rosenberg AR; Wong-Staal F; Davioud-Charvet E; Pietschmann T
    Gastroenterology; 2012 Jul; 143(1):213-22.e5. PubMed ID: 22465429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
    Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
    Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of bivalent oleanane-type triterpenes as potent HCV entry inhibitors.
    Yu F; Peng Y; Wang Q; Shi Y; Si L; Wang H; Zheng Y; Lee E; Xiao S; Yu M; Li Y; Zhang C; Tang H; Wang C; Zhang L; Zhou D
    Eur J Med Chem; 2014 Apr; 77():258-68. PubMed ID: 24650713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral activity of cuprous oxide nanoparticles against Hepatitis C Virus in vitro.
    Hang X; Peng H; Song H; Qi Z; Miao X; Xu W
    J Virol Methods; 2015 Sep; 222():150-7. PubMed ID: 26116793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry.
    Chung CY; Liu CH; Wang GH; Jassey A; Li CL; Chen L; Yen MH; Lin CC; Lin LT
    Sci Rep; 2016 Jul; 6():29969. PubMed ID: 27426693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves.
    Wahyuni TS; Widyawaruyanti A; Lusida MI; Fuad A; Soetjipto ; Fuchino H; Kawahara N; Hayashi Y; Aoki C; Hotta H
    Fitoterapia; 2014 Dec; 99():276-83. PubMed ID: 25454460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.
    Rolt A; Le D; Hu Z; Wang AQ; Shah P; Singleton M; Hughes E; Dulcey AE; He S; Imamura M; Uchida T; Chayama K; Xu X; Marugan JJ; Liang TJ
    J Infect Dis; 2018 May; 217(11):1761-1769. PubMed ID: 29373739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibitory effects of anacardic acid on hepatitis C virus life cycle.
    Hundt J; Li Z; Liu Q
    PLoS One; 2015; 10(2):e0117514. PubMed ID: 25658101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
    Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
    J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.
    Liu X; Huang Y; Cheng M; Pan L; Si Y; Li G; Niu Y; Zhao L; Zhao J; Li X; Chen Y; Yang W
    J Virol; 2013 Feb; 87(3):1649-57. PubMed ID: 23175359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.
    Kim HY; Kong S; Oh S; Yang J; Jo E; Ko Y; Kim SH; Hwang JY; Song R; Windisch MP
    Antiviral Res; 2016 May; 129():39-46. PubMed ID: 26850830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
    Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
    Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors.
    Banda DH; Perin PM; Brown RJP; Todt D; Solodenko W; Hoffmeyer P; Kumar Sahu K; Houghton M; Meuleman P; Müller R; Kirschning A; Pietschmann T
    J Hepatol; 2019 Jun; 70(6):1082-1092. PubMed ID: 30769006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.